Bleeding in Critically Ill Children With Underlying Oncologic Diagnoses

NCT04170231 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 93

Last updated 2023-10-19

No results posted yet for this study

Summary

"Bleeding in Critically Ill Children with Underlying Oncologic Diagnoses ," will be a prospective observational cohort study looking at the epidemiology of bleeding in the pediatric ICU population at MSK.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Marianne Nellis, MD, MS · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
28 Days
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-18
Primary Completion
2023-10-18
Completion
2023-10-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04170231 on ClinicalTrials.gov